Enrolling now · NCT07446439

A study testing whether tradipitant from Vanda Pharmaceuticals, an investigational anti-nausea medicine, can reduce nausea and vomiting.

Who can join
Adults 18 to 65, have nausea and vomiting, BMI 25+.
What you take
Tradipitant, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
How long it lasts
The study runs about 9 months.
What you get
The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Phase Phase 3Sponsor Vanda PharmaceuticalsDrug TradipitantClass OtherSites 10 USEnrollment target 280

What this study is for

Full study title: A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use.

Primary condition: Nausea and Vomiting. Also studied in: Obesity.

Who can join, in detail

Age 18 to 65
Sex All
BMI 25 to 40

Key inclusion criteria

  • Body Mass Index >= 25 and < 40 kg/m^2
  • No serious medical problems or chronic diseases, specifically no type I or type II diabetes

Key exclusion criteria

  • Another disorder that contributes to gastrointestinal symptoms
  • History of intolerance and/or hypersensitivity to NK-1 receptor antagonists
  • History of intolerance and/or hypersensitivity to GLP-1 receptor agonists
  • Exposure to any investigational medication within the past 60 days

Where this study is enrolling

This trial has 10 US sites across 6 states. Contact the site coordinator directly to start the screening process.

California

  • Vanda Investigational Site
    Los Angeles, California
    Vanda Pharmaceuticals202-734-3400
  • Vanda Investigational Site
    San Diego, California
    Vanda Pharmaceuticals202-734-3400
  • Vanda Investigational Site
    San Jose, California
    Vanda Pharmaceuticals(202) 734-3400

Florida

  • Vanda Investigational Site
    Tampa, Florida
    Vanda Pharmaceuticals(202) 734-3400

New Jersey

  • Vanda Investigational Site
    Hamilton, New Jersey
    Vanda Pharmaceuticals(202) 734-3400

New York

  • Vanda Investigational Site
    New York, New York
    Vanda Pharmaceuticals202-734-3400
  • Vanda Investigational Site
    Syosset, New York
    Vanda Pharmaceuticals(202) 734-3400

Texas

  • Vanda Investigational Site
    Plano, Texas
    Vanda Pharmaceuticals(202) 734-3400
  • Vanda Investigational Site
    San Antonio, Texas
    Vanda Pharmaceuticals(202) 734-3400

Virginia

  • Vanda Investigational Site
    Burke, Virginia
    Vanda Pharmaceuticals(202) 734-3400

Timeline

Started enrolling: 2026-03-27. Expected completion: 2026-12-01. Last updated on ClinicalTrials.gov: 2026-04-20.

Official source

We sync this data quarterly from ClinicalTrials.gov, the federal registry for clinical research. Before contacting a site, verify the trial is still recruiting on the official page:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

Why you can trust GLP ChartSame scoring framework applied to every program. No paid placements. No removal of unfavorable information at advertiser request. Pricing is pulled from each program's public-facing page weekly.